Literature DB >> 16228832

Patient's preferences for adjuvant postoperative chemoradiation therapy in rectal cancer.

Jean Couture1, Ron Chan, Fatima Bouharaoui.   

Abstract

PURPOSE: This study was designed to elicit patient's preferences with regard to adjuvant postoperative chemoradiation therapy in rectal cancer.
METHODS: Forty-seven previously treated colorectal cancer patients underwent a structured interview and were presented with two scenarios involving surgery for rectal cancer: surgery alone, or surgery followed by postoperative chemoradiation therapy. Acute and long-term health states for each options were described. Their willingness to trade-off side-effects for treatment efficacy was evaluated by using the probability trade-off method.
RESULTS: The age and gender distribution of the cohort were comparable with the general colon cancer population. Rectal cancer had been diagnosed in 20 individuals. The majority of patients valued their disease-free status in light of the anticipated long-term effects on their quality of life. The median point at which patients switched their preference was 5 percent, a value reflecting the critical local recurrence rate acceptable. The important items that influenced decisions were the effects on bowel function and fear of recurrence.
CONCLUSIONS: This small study demonstrates a substantial variation in patient's preferences with regard to postoperative chemoradiation for rectal cancer. Further studies in the preoperative setting are warranted.

Entities:  

Mesh:

Year:  2005        PMID: 16228832     DOI: 10.1007/s10350-005-0174-x

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  3 in total

1.  Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery: The Phase 2 Nonrandomized QuickSilver Clinical Trial.

Authors:  Erin D Kennedy; Marko Simunovic; Kartik Jhaveri; Richard Kirsch; Jim Brierley; Sébastien Drolet; Carl Brown; Patrick M Vos; Wei Xiong; Tony MacLean; Selliah Kanthan; Peter Stotland; Simon Raphael; Gil Chow; Catherine A O'Brien; Charles Cho; Cathy Streutker; Raimond Wong; Selina Schmocker; Sender Liberman; Caroline Reinhold; Neil Kopek; Victoria Marcus; Alexandre Bouchard; Caroline Lavoie; Stanislas Morin; Martine Périgny; Ann Wright; Katerina Neumann; Sharon Clarke; Nikhilesh G Patil; Thomas Arnason; Lara Williams; Robin McLeod; Gina Brown; Alex Mathieson; Amandeep Pooni; Nancy N Baxter
Journal:  JAMA Oncol       Date:  2019-07-01       Impact factor: 31.777

2.  Adjuvant chemotherapy for colorectal cancer: age differences in factors influencing patients' treatment decisions.

Authors:  Mikaela L Jorgensen; Jane M Young; Michael J Solomon
Journal:  Patient Prefer Adherence       Date:  2013-08-23       Impact factor: 2.711

3.  The impact of decision aids in patients with colorectal cancer: a systematic review.

Authors:  Jenaya Goldwag; Priscilla Marsicovetere; Peter Scalia; Heather A Johnson; Marie-Anne Durand; Glyn Elwyn; Srinivas J Ivatury
Journal:  BMJ Open       Date:  2019-09-12       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.